# Lymphatic system decline during aging

The lymphatic system is a ubiquitous and vital network of vessels, nodes, and organs responsible for maintaining interstitial fluid homeostasis, facilitating intestinal lipid absorption, and orchestrating systemic immune surveillance. Unlike the cardiovascular system, which relies on the mechanical force of the heart to circulate blood, the lymphatic vasculature depends on a delicate combination of extrinsic mechanical tissue forces and the intrinsic, spontaneous contractions of lymphatic muscle cells. This decentralized transport network propels fluid, macromolecules, and immune cells against gravity and pressure gradients, ultimately returning them to the venous circulation. 

With advancing age, the structural integrity and functional capacity of the lymphatic system undergo profound deterioration. This age-related decline—characterized by endothelial hyperpermeability, muscle cell atrophy, impaired contractility, and lymph node fibrosis—precipitates far-reaching systemic consequences. Contemporary research demonstrates that lymphatic senescence is not merely an isolated physiological shift but a core driver of systemic inflammaging, impaired metabolic regulation, and the pathogenesis of neurodegenerative conditions such as Alzheimer's disease. Understanding the precise mechanisms of lymphatic aging provides crucial insight into the progressive failure of tissue waste clearance and opens novel avenues for therapeutic intervention.

## Biological Mechanisms of Lymphatic Senescence

The degradation of the lymphatic system with age occurs at multiple biological levels, spanning gross anatomical architecture, cellular signaling pathways, and extracellular matrix composition. These compounding deficits transform the lymphatic vasculature from a highly efficient drainage and filtration network into a sluggish, highly permeable system that fosters chronic inflammation and tissue dysfunction.

### Structural Degradation of Lymphatic Capillaries and Collectors

Lymphatic fluid transport relies on an intricate balance between initial lymphatic capillaries, which absorb interstitial fluid, and collecting lymphatic vessels, which transport the fluid toward regional lymph nodes. Initial lymphatics are lined with endothelial cells connected by discontinuous, "button-like" junctions that permit the entry of fluid, immune cells, and large macromolecules into the vessel lumen [cite: 1]. Conversely, collecting vessels feature tight "zipper-like" junctions, intraluminal bi-leaflet valves to prevent retrograde flow, and a functional covering of lymphatic muscle cells (LMCs) that provide the intrinsic pumping force necessary for lymph propulsion [cite: 1, 2].

Aging induces severe structural remodeling within both types of vessels. In aged organisms, the density and branching of initial lymphatic vessels decrease significantly. Studies of the cutaneous lymphatic network indicate age-related reductions of up to 35% in initial vessel density and 25% in vessel branching [cite: 2, 3]. Concurrently, the collecting vessels undergo pathological dilation, LMC atrophy, and the destruction of essential elastic elements. This loss of elasticity frequently results in the formation of aneurysm-like "varicose bulges" along the vessel walls [cite: 4]. Furthermore, the morphological orientation of LMCs shifts from a functional, force-generating circular arrangement to a disorganized longitudinal orientation, severely compromising their ability to generate contractile force [cite: 2].

At the molecular level, this loss of contractility is driven by a reduction in the expression of crucial contractile and cytoskeletal proteins, including myosin, troponin, dynein, actin, and gelsolin [cite: 5]. Furthermore, the physiological generation of nitric oxide (NO) by endothelial nitric oxide synthase (eNOS)—a critical regulator of vessel relaxation and subsequent contraction frequency—is disrupted. In aged collecting vessels, the responsiveness to physiological shear stress and external inflammatory stimuli is blunted, leading to a diminished capacity to adjust pumping rates in response to localized tissue edema [cite: 5, 6].

### Endothelial Cell Senescence and Barrier Permeability

The endothelial cells lining the lymphatic vasculature are highly susceptible to cellular senescence, an irreversible state of cell cycle arrest accompanied by a senescence-associated secretory phenotype (SASP). Normal lymphatic endothelial cell (LEC) survival, proliferation, and function are primarily driven by Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3) signaling. Aging significantly diminishes VEGFR-3 signaling, leading to increased LEC apoptosis and widespread cellular senescence across the lymphatic network [cite: 2, 3].

A primary hallmark of an aged lymphatic endothelium is increased barrier permeability, which allows lymph fluid, unneutralized pathogens, and metabolic waste to leak back into the surrounding interstitial space. This hyperpermeability is caused by the progressive degradation of the endothelial glycocalyx—a protective, sugar-rich glycoprotein layer lining the vessel lumen—and the dissociation of critical junctional protein complexes, such as the VE-cadherin and catenin complex [cite: 4, 7]. The loss of the glycocalyx directly impairs the vessel's ability to prevent pathogen adhesion and allows potentially harmful macromolecules to escape from the collectors into the peripheral tissues [cite: 4]. Consequently, aged lymphatic vessels exhibit an increased accumulation of peri-lymphatic leukocytes and elevated nitrosative stress, establishing a localized feed-forward loop of chronic, low-grade inflammation [cite: 2, 3].

### Lymph Node Architecture and Immunosenescence

Lymph nodes function as critical filtration checkpoints and physical hubs for the adaptive immune system. The structural integrity of a lymph node is maintained by a specialized network of lymph node stromal cells (LNSCs), including fibroblastic reticular cells (FRCs), lymphatic endothelial cells (LECs), and blood endothelial cells (BECs) [cite: 8, 9]. As age advances, the architecture of the lymph node undergoes progressive deterioration, marked heavily by lipomatosis (the accumulation of adipose tissue) and fibrosis (the excessive deposition of collagen and extracellular matrix proteins) [cite: 8, 10].

This structural degradation directly impairs systemic immune function. The network of FRCs, which typically elongates and relaxes to accommodate the influx and rapid proliferation of lymphocytes during an acute immune response, loses its vital plasticity. Aged FRCs exhibit delayed proliferative responses and reduced activation, severely crippling the node's ability to expand and coordinate defenses against new pathogens [cite: 8]. Furthermore, the expression of key chemokines, such as CCL21, which is necessary for attracting dendritic cells from the periphery into the lymphatic vessels and subsequently into the draining lymph nodes, is significantly reduced in aged lymphatic endothelia [cite: 8, 10].

These localized nodal changes are inextricably linked to the broader phenomenon of systemic immunosenescence. The T-cell compartment within both the lymph nodes and the peripheral blood undergoes extensive, lifelong remodeling. There is a dramatic decline in the absolute number and functional output of naive T-cells—driven heavily by the age-related involution of the thymus gland—and a corresponding massive expansion of terminally differentiated, senescent memory T-cells [cite: 10, 11, 12]. This compositional shift severely restricts the T-cell receptor (TCR) repertoire, limiting the adaptive immune system's ability to recognize novel antigens and mount effective responses to new vaccines [cite: 10, 11, 12]. Simultaneously, the accumulation of senescent B-cells—often referred to as age-associated B cells (ABCs)—actively inhibits normal B-cell lymphopoiesis and disrupts central immune tolerance, increasing the incidence of autoantibodies and autoimmune conditions in the elderly [cite: 10, 13].

## Quantitative Physiological Decline in Lymphatic Transport

The qualitative observation of lymphatic senescence is firmly corroborated by strict quantitative metrics derived from both murine models and human clinical studies. These multi-species data illustrate a progressive, age-dependent failure in the system's mechanical ability to transport fluid and clear waste from peripheral and central tissues.

### Human Clinical Measurements of Lymphatic Pumping

In humans, the intrinsic pumping pressure of collecting lymphatic vessels demonstrates a clear, measurable inverse relationship with age. In a definitive study involving 399 healthy volunteers aged 20 to 91, researchers utilized minimally invasive indocyanine green (ICG) fluorescence lymphography combined with a custom-made transparent sphygmomanometer cuff to accurately measure leg lymphatic pumping pressure [cite: 14, 15, 16]. The cuff was inflated and gradually deflated until the fluorescent dye was visually observed exceeding the upper border, defining the absolute pumping pressure.

The analysis revealed a statistically significant negative correlation between leg lymphatic pumping pressure and advancing age (r = -0.34, p < 0.0001) [cite: 14, 15]. Individuals exhibiting poor pumping pressures—defined as falling below 20 mmHg in both legs—reported significantly higher rates of clinical leg edema and diminished overall quality of life compared to subjects with moderate (20-40 mmHg) or good (>40 mmHg) pumping pressures [cite: 16]. Notably, this age-associated decline in lymphatic pumping pressure was found to be most pronounced in women of postmenopausal age, suggesting a potential hormonal influence on lymphatic muscle cell function [cite: 14, 15].

### Murine Models of Cervical Lymphatic Clearance

Animal models provide further high-resolution quantitative data regarding the specific trajectory of this mechanical decline. A 2024 study assessing the function of superficial cervical lymphatic vessels (scLVs) in mice successfully mapped the exact progression of contractile failure over a standard mammalian lifespan [cite: 17]. 

In young mice (2 months of age), the intrinsic contraction rate of the superficial cervical lymphatic vessels averaged 13.2 contractions per minute. This baseline contractility maintained an average volumetric flow rate of 70.6 nanoliters per minute, ensuring efficient fluid turnover from the craniocervical compartment [cite: 17]. By 18 months of age, representing the onset of physiological aging, the contraction rate precipitously declined by 50% to roughly 6.6 contractions per minute, and the volumetric flow rate dropped correspondingly to 20.8 nanoliters per minute [cite: 17]. In advanced age (22 months), the contraction rate fell by 65% compared to baseline, yielding a severely depressed flow rate of only 16.9 nanoliters per minute and a 63% reduction in downstream flow velocity [cite: 17].

[image delta #1, 0 bytes]

 



### Translational Limitations and Diversity Gaps

While murine models have exponentially accelerated the discovery of lymphatic mechanisms, translational gaps complicate the direct application of these findings to human aging. Fundamental differences exist in lymphatic architecture, physiology, and gravitational exposure. For instance, mice are quadrupeds and do not experience the chronic gravitational loads on the lower extremities that bipedal humans do, fundamentally altering the mechanics of lower-limb lymphatic failure and subsequent lymphedema [cite: 18, 19]. Furthermore, while human visceral and thoracic collecting lymphatics rely heavily on intrinsic pumping to move lymph fluid upward, aspects of mouse thoracic duct physiology do not accurately mirror this specific contractility [cite: 18, 19]. 

There is also a pressing need for diverse human cohort studies. The incidence of specific lymphatic pathologies varies globally, with secondary lymphedema driven heavily by the parasitic nematode infection lymphatic filariasis in endemic regions of Asia, Africa, and the Americas, while surgical and radiotherapeutic oncologic interventions primarily drive incidence in developed nations [cite: 20, 21]. Emerging multinational longitudinal studies—such as the Health and Aging in Africa: A Longitudinal Study in South Africa (HAALSI) and the Asian Cohort for Alzheimer's Disease (ACAD)—are currently attempting to harmonize data on how biological aging, genetic markers, and environmental stressors intersect to influence cognitive and systemic lymphatic decline across diverse populations [cite: 22, 23, 24]. 

| Metric Category | Human Presentation | Murine Model Presentation | Key Translational Difference |
| :--- | :--- | :--- | :--- |
| **Lower Extremity Fluid Dynamics** | Heavily influenced by bipedal gravity; high incidence of dependent edema with age. | Quadrupedal posture minimizes dependent gravitational pooling. | Mechanical stress on initial lymphatics differs drastically. |
| **Thoracic Duct Pumping** | High reliance on intrinsic smooth muscle contractility to move fluid vertically. | Thoracic collecting lymphatics do not exhibit the same robust intrinsic pumping. | limits direct modeling of human central lymph transport. |
| **Primary Pathological Drivers** | Oncologic surgery (developed nations); Lymphatic filariasis (developing nations). | Genetic knockout models (e.g., Chy mice); surgical ablation. | Murine models rarely replicate the chronic parasitic or radiotherapeutic tissue damage seen in humans. |

## Systemic Consequences of Lymphatic Dysfunction

The deterioration of the lymphatic system is not an isolated mechanical failure; it creates a cascade of physiological deficits that influence nearly every major organ system. The most profound and highly researched implications of lymphatic senescence are observed in the central nervous system, systemic lipid metabolism, and global immune homeostasis.

### Central Nervous System Clearance and Neurodegeneration

The brain represents a unique immunological environment because it lacks a conventional parenchymal lymphatic vessel network. Instead, it relies on a highly specialized waste clearance mechanism known as the glymphatic system, which works in seamless tandem with the meningeal lymphatic vessels [cite: 25, 26, 27, 28, 29]. Cerebrospinal fluid (CSF) flows into the brain tissue along perivascular spaces, facilitated by aquaporin-4 (AQP4) water channels located on the endfeet of astrocytes [cite: 28, 30]. This fluid actively mixes with the interstitial fluid of the brain, collecting metabolic waste, cellular debris, and neurotoxic proteins, before effluxing back out toward the meninges. The meningeal lymphatic vessels, located within the dura mater, absorb this waste-laden fluid and drain it out of the skull into the deep cervical lymph nodes (dCLNs) for systemic processing and clearance [cite: 27, 31, 32, 33].

Aging induces catastrophic failures along this entire clearance axis. Meningeal lymphatic vessels undergo age-related narrowing, reduced spatial branching, and severe functional impairment, significantly slowing the paravascular influx of fresh CSF and the efflux of interstitial waste [cite: 26, 29, 31, 34]. Recent pathological data indicates that this decline is severely exacerbated by extracellular matrix remodeling in the aged dura; specifically, the progressive deposition of peri-lymphatic collagen forms a physical fibrotic barrier that constricts the vessels and prevents the efficient uptake of CSF [cite: 35]. 

The primary consequence of this impaired drainage is the accumulation of amyloid-beta (Aβ) and hyperphosphorylated tau proteins within the brain parenchyma—the widely recognized pathological hallmarks of Alzheimer's disease (AD) and other dementias [cite: 27, 34, 36, 37].

[image delta #2, 0 bytes]

 In transgenic mouse models of Alzheimer's disease (such as the 5xFAD model), the artificial ablation of meningeal lymphatics drastically increases amyloid plaque deposition and visibly worsens cognitive, spatial learning, and memory deficits [cite: 31, 34, 36, 38]. Conversely, impaired lymphatic drainage triggers a maladaptive neuroinflammatory response within the brain. The accumulation of metabolic waste provokes microglia to release inflammatory cytokines, particularly Interleukin-6 (IL-6). Elevated IL-6 alters the balance of cortical excitatory and inhibitory synaptic inputs, actively driving neuronal dysfunction and cognitive decline [cite: 38, 39].



### Biomarker Enrichment in Cervical Lymph Nodes

Because the deep cervical lymph nodes act as the primary sink for brain-derived waste, they provide a unique window into central nervous system pathology. A landmark 2025 study investigated the presence of neurodegenerative fluid biomarkers directly in human cervical lymph nodes using ultrasound-guided fine-needle aspiration [cite: 40, 41, 42]. 

The clinical findings confirmed that neurodegenerative biomarkers are highly enriched in the cervical lymph nodes compared to matched peripheral blood plasma. Specifically, phosphorylated tau 181 (pTau181) was found at concentrations averaging 4,865 pg/ml in CLN aspirates compared to 18.3 pg/ml in plasma, representing an extraordinary 266-fold enrichment [cite: 40, 41]. Amyloid-beta 40 and 42 were also significantly elevated, exhibiting an approximate 4.5-fold enrichment over plasma levels [cite: 40]. Crucially, the concentration of pTau181 in the cervical lymph nodes demonstrated a significant inverse correlation with the subject's age (r = -0.66, P = 0.001) [cite: 40, 41]. This negative correlation in living humans strongly supports the preclinical hypothesis that the meningeal-cervical lymphatic drainage pathway progressively loses its physical capacity to extract neurotoxic proteins from the brain as humans age. While absolute concentrations for certain markers like glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) were not uniformly elevated across all cohorts, the profound enrichment of tau highlights the lymphatic system's role in neurodegenerative disease tracking [cite: 40].

### Intestinal Lipid Transport and Metabolic Homeostasis

Beyond immune and neurological functions, the lymphatic system is exclusively responsible for the transport of dietary lipids from the intestine to the systemic circulation. Within the small intestine, highly specialized lymphatic capillaries known as lacteals absorb dietary fats that have been packaged into large chylomicron particles by enterocytes [cite: 1, 43]. The entry of chylomicrons into lacteals is not a passive diffusion process; it requires the active, dynamic opening of the button-like junctions between lymphatic endothelial cells, driven by ROCK (Rho-associated kinase) signaling and heavily modulated by the VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 signaling pathways [cite: 1, 44].

While baseline lipid digestion and absorption remain relatively well-preserved during healthy aging, the dynamic adaptability of this intestinal transport system declines precipitously [cite: 45]. Under physiological stress or intercurrent illness, aged animals and humans display significant impairments in the assembly and transport of lipoproteins from the enterocytes into the lymphatic network [cite: 45]. Alterations in intestinal lymphatic structure, including changes in junctional integrity (pathological zippering) and the decline of molecular regulators like Calcitonin Receptor-Like Receptor (CALCRL), can lead to systemic dyslipidemia and predispose elderly individuals to compounding metabolic conditions such as severe obesity, insulin resistance, and hepatic steatosis [cite: 43, 44, 46].

### Adipose Tissue Senescence and Chronic Systemic Inflammation

Lymphatic dysfunction is recognized as a major contributor to systemic "inflammaging"—the chronic, low-grade inflammation characteristic of advanced age that precedes overt disease. In peripheral tissues, notably visceral adipose tissue, the failure of lymphatic vessels to efficiently clear cellular debris, immune complexes, and metabolic byproducts leads to a significant buildup of senescent cells [cite: 47]. 

These localized senescent cells, including aged macrophages and T-lymphocytes, accumulate in adipose tissue and express markedly elevated levels of classical senescence markers like CDKN2A (p16) and CDKN1A (p21) [cite: 47]. In response to stress, they secrete a potent, toxic cocktail of pro-inflammatory cytokines, chemokines, and matrix metalloproteinases collectively known as the senescence-associated secretory phenotype (SASP) [cite: 13, 47, 48]. The sustained SASP environment aggressively upregulates CD38 in surrounding immune cells, leading to the rapid depletion of systemic NAD+ levels. This decline in NAD+ further drives metabolic dysfunction and compromises distant vital organs, ultimately contributing to age-related cardiovascular disease and multiorgan fibrosis [cite: 13, 47]. 

## Clinical Interventions and Pharmacological Targets

The recognition of lymphatic decline as a primary root cause of age-related pathology has catalyzed the rapid development of novel pharmacological and surgical interventions. These treatments are aimed at rejuvenating lymphatic structure, restoring fluid homeostasis, and actively clearing neurotoxic waste. 

### Pharmacological Restoration of Lymphatic Function

Pharmacological strategies for addressing lymphatic and systemic aging are broadly categorized by their mechanistic targets. These approaches focus either on the active restoration of vessel growth and contractility or the targeted elimination of the toxic cellular environments that paralyze lymphatic function.

1. **Lymphangiogenic Growth Factors:** Vascular Endothelial Growth Factor C (VEGF-C) is the primary signaling protein responsible for the physiological generation and maintenance of lymphatic vessels [cite: 38, 49]. In aged mouse models, the delivery of VEGF-C via viral vectors (such as AAV-VEGF-C) directly into the cerebrospinal fluid has successfully stimulated the growth of new meningeal lymphatics, increased existing vessel diameter, and restored the drainage of macromolecules to the cervical lymph nodes [cite: 26, 38, 50]. Crucially, this targeted intervention was shown to rapidly reduce IL-6 inflammatory signaling and reverse age-associated cognitive and memory deficits [cite: 38, 39]. 
2. **Contractility Enhancers:** Researchers have explored pharmacological agents that directly target the smooth muscle tone of lymphatic vessels to restore the mechanical pumping action lost to age. The topical application of prostaglandin F2α analogs to the exposed cervical lymphatic vessels in aged mice successfully restored spontaneous vessel pulsation, diminished retrograde lymph flow, and enhanced overall CSF clearance [cite: 17, 27, 50]. 
3. **Senolytics:** Senolytic compounds are designed to selectively induce apoptosis in senescent cells, thereby permanently removing the source of the tissue-destructive SASP [cite: 51, 52, 53]. The combination of Dasatinib (a targeted tyrosine kinase inhibitor) and Quercetin (a naturally occurring flavonoid) is the most extensively studied senolytic regimen [cite: 53, 54, 55]. By clearing senescent cells from the peri-lymphatic tissue and degraded lymph nodes, senolytics actively reduce chronic inflammation, enhance localized tissue repair, and have been shown to improve cardiac function, exercise endurance, and cognitive performance in preclinical models [cite: 53, 54].
4. **Senomorphics:** Unlike senolytics, senomorphics (such as rapamycin and metformin) do not kill the senescent cell. Rather, they modulate cellular behavior by suppressing the active secretion of SASP factors, effectively muting the inflammatory signal that degrades lymphatic and systemic health without altering total cell counts [cite: 51, 54].

| Intervention Class | Primary Mechanism of Action | Target Biological Pathway | Current Level of Evidence |
| :--- | :--- | :--- | :--- |
| **Lymphangiogenics** (e.g., VEGF-C, HGF) | Stimulates lymphatic endothelial cell proliferation and vessel generation; expands meningeal drainage. | VEGFR-3 / Non-VEGFR-3 pathways | Preclinical (Mouse Models); highly effective in reversing cognitive decline in AD models. |
| **Contractility Agents** (e.g., Prostaglandin F2α) | Restores smooth muscle tone and pumping frequency of collecting lymphatic vessels. | ROCK / Smooth Muscle Actin | Preclinical; demonstrates acute restoration of CSF outflow. |
| **Senolytics** (e.g., Dasatinib + Quercetin) | Selectively induces apoptosis in senescent cells, completely removing the source of SASP inflammation. | Apoptosis Resistance Pathways | Early Clinical / Off-label use; visibly reduces systemic senescent cell burden. |
| **Senomorphics** (e.g., Rapamycin, Metformin) | Suppresses the secretion of inflammatory SASP factors without eliminating the underlying senescent cell. | mTOR, AMPK | Clinical; broad multi-hallmark anti-aging physiological effects. |

### Surgical Interventions in Central Nervous System Drainage

In human medicine, the translation of lymphatic enhancement has briefly taken an aggressive surgical route, particularly for the treatment of severe neurodegenerative diseases. Deep cervical lymphaticovenous anastomosis (dcLVA) is an innovative, albeit highly controversial, microsurgical procedure designed to bypass physical lymphatic bottlenecks [cite: 37, 56]. The procedure involves manually conjoining the deep cervical lymphatic vessels that drain the brain directly with adjacent veins in the neck, establishing a low-resistance, high-flow outflow tract for cerebrospinal fluid and metabolic waste [cite: 37, 56]. 

Before being formally restricted pending further standardized safety trials in 2025, dcLVA was performed on over 2,000 patients across numerous provinces in China. Preliminary, uncontrolled case series reported short-term improvements in cognitive scores (e.g., MMSE improved by an average of two points) and favorable trends in AD biomarkers (Aβ and tau) [cite: 37, 56]. However, the broader international medical community maintains strict, calibrated uncertainty regarding the procedure. Critics highlight that the complex anatomy of human lymphatic drainage is still incompletely mapped, translation from rodent lymphatic pathways is uncertain, and the reported cognitive improvements may be heavily subject to placebo effects, perioperative physiological fluctuations, or natural disease variations [cite: 37, 56]. 

## Evidence-Based Lymphatic Medicine Versus Commercial Detoxification

As the scientific understanding of the lymphatic system has firmly entered the public consciousness, a robust, highly profitable commercial wellness industry has emerged. This industry heavily promotes "lymphatic detox" products, unproven supplements, and rapid-weight-loss routines. It is crucial to delineate evidence-based physiological support from marketing trends that fundamentally misrepresent basic lymphatic biology.

### Deconstructing Lymphatic Detoxification Claims

The concept of chemically "detoxifying" the body via the lymphatic system is a biological misnomer. The physiological breakdown, metabolism, and neutralization of environmental toxins, heavy metals, and xenobiotics are performed almost exclusively by the phase I and phase II enzymatic pathways of the liver and ultimately excreted by the kidneys [cite: 57, 58, 59]. The lymphatic system's actual role in waste clearance is strictly limited to the physical transport of large biological macromolecules, dead cellular debris, excess interstitial fluid, and immune complexes to the lymph nodes for filtration and eventual return to the bloodstream [cite: 57, 58].

Products marketed heavily for "lymphatic detox"—such as transdermal adhesive patches (e.g., NutriSpot neck and foot patches) or aggressive botanical supplements—lack any robust, independent clinical validation [cite: 59, 60]. Adhesive patches that turn a dark, sludgy color overnight rely entirely on simple chemical reactions between body sweat and the patch ingredients (often wood vinegar or ginger), not the physical extraction of systemic toxins through the skin barrier [cite: 60]. Similarly, herbal supplements containing ingredients like cleavers, dandelion, or heavy doses of selenium may offer mild, general diuretic or antioxidant properties. However, there is zero peer-reviewed evidence that they chemically "flush" the lymphatic system, reverse established secondary lymphedema, or induce fat release independent of a strict caloric deficit [cite: 57, 59, 61, 62]. 

### Clinically Validated Lymphatic Therapies

While the commercial "detox" paradigm is medically unsupported, evidence-based physical interventions can successfully optimize lymphatic fluid dynamics. Because the lymphatic system relies heavily on external mechanical forces to compensate for intrinsic pumping deficits, physical movement and targeted mechanical therapies are paramount [cite: 57, 58, 63]. 

Manual Lymphatic Drainage (MLD) is a clinically validated, gentle, rhythmic massage technique specifically designed to stimulate the flow of lymph fluid and visibly reduce interstitial fluid pressure [cite: 57, 58, 64]. Medical-grade MLD, particularly when combined with rigorous compression therapy, remains the established gold standard for managing secondary lymphedema and post-surgical oncologic swelling [cite: 57, 64]. MLD does not chemically "cleanse" organs of toxins. Instead, by physically directing pooled fluid toward functioning nodal clusters, it actively alleviates the mechanical burden of tissue edema and functionally supports the body's natural immunological filtration processes [cite: 57, 58]. 

Additionally, emerging non-invasive technologies like photobiomodulation (Red and Near-Infrared Light Therapy) are being actively studied for their direct cellular effects on lymphatic contractility. Preliminary evidence indicates that specific, targeted wavelengths (660nm and 850nm) may interact with lymphatic endothelial cells to enhance mitochondrial ATP production and promote localized nitric oxide release. This process potentially increases the intrinsic contraction frequency of lymphatic muscle cells, aiding in the systemic reduction of localized swelling and supporting post-surgical recovery [cite: 65].

## Sources
1. [The Future of Lymphedema Potential Therapeutic Targets for Treatment](https://lymphoedemaeducation.com.au/wp-content/uploads/2023/07/The-Future-of-Lymphedema-Potential-Therapeutic-Targets-for-Treatment.pdf)
2. [Gene Therapy with VEGF-C Restores Lost Lymphatic Drainage of Cerebrospinal Fluid in Aged Mice](https://www.fightaging.org/archives/2025/03/gene-therapy-with-vegf-c-restores-lost-lymphatic-drainage-of-cerebrospinal-fluid-in-aged-mice/)
3. [Pharmacological Interventions in Aging](https://www.mdpi.com/1422-0067/26/19/9372)
4. [Inhibition of VEGF-C Modulates Distal Lymphatic Remodeling and Secondary Metastasis](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0068755)
5. [Current Advances in Therapies Preventing Lymphatic Metastasis](https://pmc.ncbi.nlm.nih.gov/articles/PMC8787832/)
6. [LERN Gaps Summary](https://lymphaticnetwork.org/documents/LERN_2024_Gaps_Summary.pdf)
7. [Lymphatic vessels in mice and humans alike, yet different](https://www.uu.se/en/news/2020/2020-05-04-lymphatic-vessels-in-mice-and-humans-alike-yet-different)
8. [Lymphatic Imaging and Animal Models of Disease](https://pmc.ncbi.nlm.nih.gov/articles/PMC3938259/)
9. [Mapping lymph node lymphatic vessels in mice and humans](https://www.sciencedaily.com/releases/2020/05/200505093131.htm)
10. [Animal Models of Lymphedema](https://pmc.ncbi.nlm.nih.gov/articles/PMC12096149/)
11. [Senolytics in Anti-Aging and Functional Medicine](https://drstavy.com/blog/senolytics-in-anti-aging-and-functional-medicine/)
12. [Aging, Senolytics, and Healthspan](https://pmc.ncbi.nlm.nih.gov/articles/PMC12524491/)
13. [Senolytics as a Treatment for Aging and Immunosenescence](https://www.fightaging.org/archives/2025/05/senolytics-as-a-treatment-for-aging-and-immunosenescence/)
14. [Senolytics: The New Way to Prevent Aging](https://www.longevilab.com/en/senolytics-the-new-way-to-prevent-aging)
15. [Anti-Aging Research 2024: New For 2025](https://int.livhospital.com/anti-aging-research-2024-new-for-2025/)
16. [Glymphatic System Research in Neurodegenerative Diseases](https://pmc.ncbi.nlm.nih.gov/articles/PMC12504467/)
17. [HAALSI Study on Aging in South Africa](https://hsph.harvard.edu/news/decade-long-research-project-that-explores-aging-in-south-africa-receives-nih-nia-funding-for-additional-waves-and-national-expansion-with-a-special-emphasis-on-cognitive-health/)
18. [Brain Lymphatic Drainage System in Aging and Neurodegenerative Diseases](https://pdfs.semanticscholar.org/b9b2/000247258b69eec97a287911f8bb6b1b1869.pdf)
19. [Lymphangiogenesis in Aging and Aging-Associated Diseases](https://www.researchgate.net/publication/382818851_The_emerging_importance_of_lymphangiogenesis_in_aging_and_aging-associated_diseases)
20. [Glymphatic System Dysfunction in Neurodegenerative Diseases](https://pubmed.ncbi.nlm.nih.gov/38345416/)
21. [Lymphatic Detox Review and Medical Perspectives](https://www.medanta.org/gurugram-360-degree/welcome/internal-view/medical-tech/?xml=data:image/gif;imagebase64;base64,PGtycGFubyBvbnN0YXJ0PSJsb2FkcGFubygnL1wvdmlkZW8udW5ray50b3Ava3JwbWFsZS9BSkhuZ2ZQTXRjTCcpOyI+PC9rcnBhbm8+)
22. [NutriSpot Neck Lymphatic Detox Patch Reviews](https://withwonderandwhimsy.com/?id=nutrispot-neck-lymphatic-detox-patch-reviews-2026-harmless-tool-or-marketing-trick)
23. [Nushape Red Light Therapy](https://www.nushape.com/)
24. [Lymphatic Flow and Wellness Practices](https://www.lemon8-app.com/@mayajanaeee/7611273191079576078?region=us)
25. [Lymphatic Drainage Facials and Scope of Practice](https://purespadirect.com/blogs/pure-spa-direct-blog/how-to-offer-lymphatic-drainage-facials-without-medical-scope-creep-the-spa-pros-safe-savvy-guide-to-tapping-into-the-trend)
26. [Aging Decreases Skin Lymphatic Function](https://pmc.ncbi.nlm.nih.gov/articles/PMC9261401/)
27. [Age-Related Changes in T-Lymphocytes](https://pmc.ncbi.nlm.nih.gov/articles/PMC11808020/)
28. [Quantitative Measurement of Lymphatic Function](https://jnm.snmjournals.org/content/43/3/318)
29. [Aging of Lymph Nodes and Immune System](https://pmc.ncbi.nlm.nih.gov/articles/PMC8621398/)
30. [Aging of the Lymph Transport System](https://pmc.ncbi.nlm.nih.gov/articles/PMC3609635/)
31. [Lymphatic System Detox Evidence-Based Natural Support](https://getgutted.co/blogs/news/lymphatic-system-detox-evidence-based-natural-support)
32. [Lymphatic Drainage Massage Detox Truth](https://ubiehealth.com/doctors-note/lymphatic-drainage-massage-detox-truth-73-myths-hq15e8)
33. [Red Light Therapy for Lymphatic Drainage](https://www.youlumistore.com/blogs/red-light-therapy-guide/red-light-therapy-lymphatic-drainage-detox)
34. [Can Detoxing Help Reduce Cancer Risk?](https://www.bcpp.org/can-detoxing-help-reduce-breast-cancer-risk/)
35. [Lymphatic Drainage Evidence and Claims](https://www.boots.com/healthhub/a-z-conditions/lymphatic-drainage)
36. [Current Time in Japan](https://www.google.com/search?q=time+in+Japan)
37. [Current Time in China](https://www.google.com/search?q=time+in+China)
38. [Current Time in South Korea](https://www.google.com/search?q=time+in+South+Korea)
39. [Brain Lymphatic Drainage System and Health](https://pmc.ncbi.nlm.nih.gov/articles/PMC11144931/)
40. [Meningeal Lymphatics Linked to Aging and Alzheimer's](https://www.fiercebiotech.com/research/brain-s-recently-discovered-lymphatic-system-linked-to-aging-and-alzheimer-s)
41. [Boosting Lymphatic Function to Combat Cognitive Decline](https://www.alzheimers.gov/news/could-boosting-lymphatic-function-combat-age-related-cognitive-decline)
42. [Meningeal Lymphatic Vessels in Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/38430054/)
43. [Functional Aspects of Meningeal Lymphatics in Ageing](https://profiles.wustl.edu/en/publications/functional-aspects-of-meningeal-lymphatics-in-ageing-and-alzheime/)
44. [Asian Cohort for Alzheimer's Disease (ACAD) Study](https://www.broadinstitute.org/publications/broad1372256)
45. [ACAD Alzheimer's Study in Asians](https://reports.mountsinai.org/article/psych2025-02-acad-alzheimers-study-in-asians-1)
46. [Glymphatic System and Neurodegenerative Diseases Bibliometric Analysis](https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1598608/full)
47. [Cross-National Health Comparisons in East Asia](https://pmc.ncbi.nlm.nih.gov/articles/PMC8671655/)
48. [Deep Cervical Lymphatic-Venous Anastomosis (dcLVA) in Alzheimer's](https://www.alzforum.org/news/research-news/stitch-vein-vessel-plumbing-fix-alzheimers-or-invasive-placebo)
49. [Estimating the Population Burden of Lymphedema](https://lymphaticnetwork.org/documents/Rockson_Estimating_Incidence_LE.pdf)
50. [Lymphedema Prevalence and Healthcare Impact](https://journals.librarypublishing.arizona.edu/lymph/article/6377/galley/5942/download/)
51. [Global Impact of Lymphedema on Quality of Life](https://www.researchgate.net/publication/372247031_Global_impact_of_lymphedema_on_quality_of_life_and_society)
52. [Epidemiology of Lymphoedema](https://www.mdpi.com/2073-4409/14/24/1955)
53. [The Incidence of Lymphedema](https://lymphaticnetwork.org/living-with-lymphedema/the-incidence-of-lymphedema)
54. [Aging, Senescence, and Cardiovascular Disease](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.125.325637)
55. [Meningeal Lymphatics and Brain Solute Clearance](https://pmc.ncbi.nlm.nih.gov/articles/PMC12687538/)
56. [Exercise-Induced Cardiac Lymphatic Remodeling](https://steelelabs.mgh.harvard.edu/timothy_padera/publications?all=true)
57. [Age-Related Changes to Lymph Node Stromal Cells](https://pmc.ncbi.nlm.nih.gov/articles/PMC11896299/)
58. [Omega-3 PUFAs and Meningeal Lymphatic Function](https://pmc.ncbi.nlm.nih.gov/articles/PMC12593584/)
59. [Extracellular Matrix Remodeling Impairs CSF Clearance](https://pmc.ncbi.nlm.nih.gov/articles/PMC12007191/)
60. [Surgical Enhancement of CNS Metabolic Waste Clearance](https://pmc.ncbi.nlm.nih.gov/articles/PMC12811783/)
61. [Glymphatic Function Assessment and Rhythms](https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1598608/full)
62. [Non-Pharmacologic Glymphatic Therapies](https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Glymphatic_Therapies_%28non-pharmacologic%29.pdf)
63. [Differential Impact of Lymphatic Outflow Pathways](https://rupress.org/jem/article/222/2/e20241752/277202/Differential-impact-of-lymphatic-outflow-pathways)
64. [Targeting Brain Drainage Rejuvenates Memory](https://neurosciencenews.com/lymphatic-system-aging-memory-28507/)
65. [Enhancing Lymphatic Drainage Restores Memory in Aged Mice](https://www.technologynetworks.com/neuroscience/news/enhancing-lymphatic-drainage-restores-memory-in-aged-mice-397535)
66. [Gene Therapy with VEGF-C Restores Drainage in Aged Mice](https://www.fightaging.org/archives/2025/03/gene-therapy-with-vegf-c-restores-lost-lymphatic-drainage-of-cerebrospinal-fluid-in-aged-mice/)
67. [Exercise Enhances Meningeal Lymphatic Drainage](https://pmc.ncbi.nlm.nih.gov/articles/PMC12291319/)
68. [Meningeal Lymphatic Vessel Development and Pruning](https://www.lerner.ccf.org/news/article/?title=Meningeal+lymphatic+vessel+development+and+pruning+impact+brain+function+over+a+lifetime&id=17efbbeafbb871a6115844fffcc163d9415d1a27)
69. [Aging of Lymph Nodes and Immune Response](https://pmc.ncbi.nlm.nih.gov/articles/PMC8621398/)
70. [Glymphatic System and CSF Waste Clearance](https://pmc.ncbi.nlm.nih.gov/articles/PMC10471172/)
71. [Aging Causes Decreased Lymphatic Function and VEGFR3 Signaling](https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2022.864860/full)
72. [Lymphatic Senescence and Functional Alterations](https://www.mdpi.com/2079-7737/10/4/293)
73. [Reviewing the Aging of Lymphatic Vessels](https://www.fightaging.org/archives/2019/09/reviewing-the-aging-of-lymphatic-vessels/)
74. [Neurodegenerative Fluid Biomarkers in Cervical Lymph Nodes](https://academic.oup.com/brain/article/148/2/394/7829162)
75. [Biomarkers Enriched in Human Cervical Lymph Nodes](https://mayoclinic.elsevierpure.com/en/publications/neurodegenerative-fluid-biomarkers-are-enriched-in-human-cervical/)
76. [Brain Biomarkers in CLNs - Brain Journal Publication](https://pubmed.ncbi.nlm.nih.gov/39432679/)
77. [Blood-Based Biomarkers of Aging and Neurodegeneration](https://pmc.ncbi.nlm.nih.gov/articles/PMC12760455/)
78. [Biomarkers Predict Alzheimer's Risk](https://www.gesundheitsindustrie-bw.de/en/article/news/blood-based-biomarkers-allow-early-prediction-alzheimers-risks)
79. [T-Cell Senescence and Immunosenescence](https://pmc.ncbi.nlm.nih.gov/articles/PMC12659517/)
80. [Cellular Senescence and Interorgan Communication](https://journals.physiology.org/doi/10.1152/physiol.00017.2025)
81. [Age-Related Changes in the T Cell Compartment](https://academic.oup.com/jimmunol/article/214/5/872/8015966)
82. [Immunosenescence and Senescent Cell Clearance](https://pmc.ncbi.nlm.nih.gov/articles/PMC12487400/)
83. [T-Cell Senescence in the Tumor Microenvironment](https://aacrjournals.org/cancerimmunolres/article/13/5/618/762125/T-cell-Senescence-in-the-Tumor-MicroenvironmentT)
84. [Effects of Aging on Intestinal Lipid Absorption](https://pubmed.ncbi.nlm.nih.gov/8430793/)
85. [Intestinal Cholesterol Transport in Lymphatic Vessels](https://erepo.uef.fi/bitstreams/24ae9ff7-d041-4d2f-8755-290945a02bad/download)
86. [Intestinal Lipid Transport in Lymphatic Vessels](https://pubmed.ncbi.nlm.nih.gov/31361624/)
87. [Chylomicron Absorption and Lipid Homeostasis](https://www.researchgate.net/publication/334758315_Intestinal_lymphatic_vessels_and_their_role_in_chylomicron_absorption_and_lipid_homeostasis)
88. [Lacteal Junction Remodeling and Lipid Absorption](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.123.322607)
89. [Systemic Perturbation of Ageing Circuitry](https://www.biorxiv.org/content/10.1101/2025.01.09.632127v1.full-text)
90. [Glymphatic and Lymphatic Communication](https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Glymphatic_Therapies_%28non-pharmacologic%29.pdf)
91. [Ageing of Lymph Node Stromal Cells](https://pmc.ncbi.nlm.nih.gov/articles/PMC11896299/)
92. [Immune Surveillance and Clearance of Senescent Cells](https://pmc.ncbi.nlm.nih.gov/articles/PMC12970235/)
93. [Aging and Disease - Systemic Inflammation](https://www.aginganddisease.org/EN/PDF/10.14336/AD.2025.0861)
94. [Immunosenescence in Aged Lymph Nodes](https://pmc.ncbi.nlm.nih.gov/articles/PMC12659517/)
95. [Exploring Lymph Node Stroma Ageing](https://www.researchgate.net/publication/389028302_Exploring_Lymph_Node_Stroma_Ageing_Immune_Implications_and_Future_Directions)
96. [Ageing of Lymph Node Stromal Cells - Details](https://pmc.ncbi.nlm.nih.gov/articles/PMC11896299/)
97. [Meningeal Immunity and Cellular Senescence](https://journals.physiology.org/doi/10.1152/physiol.00017.2025)
98. [SASP and Adipose Tissue Senescence](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.125.325637)
99. [Influence of Age and Gender on Leg Lymphatic Pumping Pressure](https://pubmed.ncbi.nlm.nih.gov/22165581/)
100. [Lymphatic Decline in Healthy Geriatric Volunteers](https://pmc.ncbi.nlm.nih.gov/articles/PMC9261401/)
101. [Human Lymphatic Pumping Measurements](https://journals.librarypublishing.arizona.edu/lymph/article/3705/galley/3748/download/)
102. [Low Lymphatic Pumping Pressure and Leg Edema](https://pubmed.ncbi.nlm.nih.gov/26091410/)
103. [Lymphatic Pump Protocol on Blood Cells](https://www.researchwithrowan.com/en/publications/the-short-term-effect-of-a-lymphatic-pump-protocol-on-blood-cell-/)
104. [Restoration of Cervical Lymphatic Vessel Function in Aging](http://hajim.rochester.edu/me/sites/kelley/papers/Du2024.pdf)
105. [Nasal Lymphatics and CSF Outflow](https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Glymphatic_Therapies_%28non-pharmacologic%29.pdf)
106. [Restoring Cervical Lymphatic Drainage in Aging](https://www.researchgate.net/publication/383154061_Restoration_of_cervical_lymphatic_vessel_function_in_aging_rescues_cerebrospinal_fluid_drainage)
107. [Nature Aging Study on Cervical Lymphatics](https://ouci.dntb.gov.ua/en/works/4Eeeda24/)
108. [Glymphatic Transport in Neurodegeneration Models](https://pmc.ncbi.nlm.nih.gov/articles/PMC11667077/)
109. [Biomarkers in Neurological Conditions](https://pmc.ncbi.nlm.nih.gov/articles/PMC12155447/)
110. [Deep Cervical Lymphaticovenous Anastomosis](https://pmc.ncbi.nlm.nih.gov/articles/PMC12746049/)
111. [Bulk CSF Flow and Brain Waste Clearance](https://www.biorxiv.org/content/10.64898/2026.04.09.717306v1.full-text)
112. [Cervical Lymph Node Structural Alterations in AD](https://www.researchgate.net/publication/400283542_Structural_and_vascular_alterations_of_deep_cervical_lymph_nodes_in_early_Alzheimer's_disease)
113. [Aβ Localization and Lymphatic Transport](https://www.mdpi.com/2073-4409/14/22/1754)
114. [Cupping Therapy and Lymphatic Drainage](https://prefeitura.aracaju.se.gov.br/uploaded-files/L7Bkrv/8AD274/CuppingTherapyForKneePain.pdf)
115. [Lymphatic Facial Massage and Detox Claims](https://www.lemon8-app.com/@daniellehabash/7545954743760273951?region=us)
116. [LymphaFlo Supplement Claims](https://www.newswire.com/news/lymphaflo-review-2026-dont-buy-everfaith-supplement-without-reading-this-first)
117. [LymphaFlo Marketing Page](https://usa-lymphaflo.com/)
118. [Lymphatic Detox Massage Wellness Spa](https://www.worldsprings.com/blog?page=6)
119. [Data Extraction from Unno et al 2011](https://pubmed.ncbi.nlm.nih.gov/22165581/)
120. [Data Extraction from Du et al 2024](http://hajim.rochester.edu/me/sites/kelley/papers/Du2024.pdf)
121. [Data Extraction from 2025 Brain Study](https://academic.oup.com/brain/article/148/2/394/7829162)

**Sources:**
1. [ahajournals.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEiMCF7u0WFgR-qDrmbPK4nLdj2fX_5K4aHgti9OVVA-bluo5oXAaJXHGQtWFQjwo71bBqp4DcHzWEasvm7mT-4SPpmwH1U_t5Ec3jyCY5hTKkv4_io8KYielajTfoI80sX6GP5Tkw-OXGlJ8GHU3R3xoVF)
2. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH97OSo0Tsg_n2yhMdDtbr_Fld_2B__IGhKHtmRv0jbPCR9AIdH9ZNd5BveX2SuL6VLedkbqAPZrlMjUaV9IXrygauoZ8urCEdI3_F2VSK91iN7pkKKPGy9SVeI25M0rUJP3xKOJo3v)
3. [frontiersin.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFlMO_mUSIZgs1j8l7EbhN6WdwcFaa0jxmwcKHE4sE8_IQIF6XoQ_mAsdf6LKMaCmRubt-adbrUOHpuWn7TbfIWQpe1e42Xuh17cL5XQGUt1jb_LYTO3rpRLUx-lmp8-kHC5o0GWfu6l8WcYnuFsmXR_X5dTLmALA8QdrOKHWas1V38EgFldwb9)
4. [fightaging.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGxWG1eJWg-v-Cnph5lFNjZbr7zx3cGbHr2IlEj-2IQukZQKsXcgIpUvKn7L-ugSzjDvgBHum3ET6mBLV_Xi59pbf5BXJ9HIJUSahiFoZ_uIaM3dK31IWzojLq8_VRKjF_hv0-2ltJom8fTDCeO5WT9PcKnghlHRN62vpIG5yNA5CCZ1rJuBNbC_UnT)
5. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH2ahRcoyTEVeZj3ePZLEQSlHxyV7j08kzbXjEsE79mcw31z6pOt9TW9tzfrZgqrhS_8X0MizYDhLlpG_b83RRAG4_riY4wRliyRkJhM8PxTqan3RbtK43JniSnbCA=)
6. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHO9vbjXQCzZmQUQT8Z3HvxJlEQBwGQdVAfB-FCqQFRZvphmEBYivb7nSwS4RngCXi88Nzs7GaTt4RqWNN8tB4x67SOGA3JWIp0UlaWRjaKJnMh4jQQSRa6QiZK7XuFVPmAGJ5sB7Uz)
7. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQESe9zpg1UYGQ4NA6z-y723iYps2Epoqaek2gjloKI09E-6mdgb3aQAo3glEFnIY7SE6bkj18uUdu97siGlGArUfagBA4MYhOmaCSD7BrkA2bs1CYukqc6k1VddI5IAraVLz5EFvqsy)
8. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEa1ZRkXPXVsOBHC_Ng8Cpa17UiidFuhXUY-54MUaKsDnpSCH7n1f2hrvm71v7l1C91uquJSb0YjoGzqPE4oXNXX1vUbRZJCZbp9tXXAOeTW6Ss1NA5qHTJOCPeZji5ioAKLQc9o4OhDw==)
9. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHFXkRSIBlKuBFZy-AmoqZi1BThM89zWGtO2BPyZt4_3DtOi7bMO4FgYcX7n60zwJtehAi1Q5xbgyxS7csOpjVcfgMr0Ez04rFzlFiQJQYjOPKLuHD6MZ5nPtIlrFA_Kaqt0c_DRNS894gf7oErcxfjuprN3PYEJj0KkV8BpEIv_3FP4ruFXt7pRzt6FskhosvxlE37dkWzCzIC7ibf7I65nLyH4YDzvRT9dDbJc5hF_cy-e7O6)
10. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHX2I84bdGkd1Il4As3m0f4JXW-I1f1-1nUljrxl4TJU9QLn8_wImnTziofwV13PQE2nviOBDQoYEJIPXzwWsrO-wHGHXEKrgNz845izAWURKJNObzztinD8fZdfMLortSUp5DVHnMs9w==)
11. [oup.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGMQ4-_GmPvkhdExTtyEtUu8s7vkZogqFgagouWRbqUZ4DzVnKyfir421Nd9RMSuu9f_fVuDi0t5MXv7pLBUSd4iWa-lHPLYH7m5b6DcUu2EJtXWgPImexS3qZqqzbjWtQc6Ddy75oYTBg0EtBS_TkOdg==)
12. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF6U4Rxqzjdorlm_Ke8KTpkAcNv6BKMuyQuD5wyQcUOAWgtWsGi1R2zGqB5dHPikIadCinulotOooHWR72fKsR_BN0OAbssBdm8zZ_vqHsmtlRVAwu471RDDl1YSBQg2d89eXN9QSQ5jg==)
13. [physiology.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFJKalZu318LqeObHgiz6ZsmYYKjiiHKOfPZZQXTUJhQD9sAPg_GVtbuNPlFg5ypaSfsWaR2FcwraS4KZVHw0u2GUTvh-aKUs44M2MnSAykxVF8zq8V5WQpZkLWKNBtrG5VDcboWuVnuDJBE2IeZ6N3Lf3xDQ==)
14. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFaL2gzw-0X1D6OwfVSEBWpZPqemmjf-vFXGYs50VEE6pZ_d4ywSU96XMyi_1d8yDSKB5_K1y-RB6tMghMLlAVLwr2smfnl0nPMMYHNraRlPVSmA7VNpSId79k3ElIZ1Q==)
15. [arizona.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEct520AiDV7Y4gvJSgZEt77n2jQTVq3zTFFGY_1TrulSLgmM1kpJ3j48o7lxBlZF5LJRvHYEKjz6nEtBM7g3QpZPVk4W1Ae55CCScSUzGP2tJHdUsBFW72AsMiloYLecg-u6kMA_sMSG0bHXt3fYkpDk78x5yC71Elyfi3o21tXCpgLYHNcts6bg4HDy8=)
16. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGkBDT54RLJT0SeWEva97MnT1J94-4vsTVdD3P6jED0Y8iU_LCsVeITeF3kD2dtK4fx3xD6Ht3sRnRm6coNppQeQUce9VKpjziFmJAQHrnWI8MqLUUFnTLV6YLN8O9wRQ==)
17. [rochester.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEqKMi3IdJu9AJItj7hSebsK6kmBpAEodeRb_7QAA-w-1VD2XA3Ap_mNTfuIUu13MJvhOzNVD1BPJ4ocKDiEBXHbcaKl474ynKLxPdgjZ1XWYW4ISJ8C8je7z_-YUEcnINX8ahVjrbQOnB_z18MnmrK_Kk=)
18. [lymphaticnetwork.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFfMXzPoh1gWt9iYDkBDGsN6_ZZIum0R9K3M5muUJ1aQz5C6JBZNyp6uvKmmnbf8HMK-S2fOmXoszK1L_ybr94s9t0vgzzT5OVQ7V-rnZl875G_HP_U-u5tkl9idFb1aisECPZisU_TgDpIbLPxox4HTtJRLYmbvQ==)
19. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQETkkBEIJ0ItlAyU3JMGvt7z4L41x66FoQwo2Ng95ANfv0JRypyH-mAezz7grUa9egTKG7_BUXvJ8X-K87T7t0eccFratrT2Quk6dNYxuRX0mcR8n_Fp2zpofLM6R0X7nUfoRtI68cs)
20. [lymphaticnetwork.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGySGiK9NF6ZaPfTGJxXmPmfCfypUjtlKngK2o7g7ESeNNw0lL7SX0XQJb80K6gCCr_yZMWPwEXu6KNvAErkWrS61eZkxoX699dqn3F9X2FKrdITP7oYnnInmwcBHp-9ovQuPzYJW1ye_bn19qx1GLnrhZKdx_VQGqnaavlyMGCDA==)
21. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFT5Toc2VJ95EMPC6z4Gq0PbD4cLLT9XNiyG1-hqIUWTFrIhLL-L_H2nm5tqEd3M5UYa-ZtvVCqsAf1GO9LnC5tEC0FHTq_m0IIx75PDM4GlxEPegPJJBCtnhkQc82U6qzET-jGEguWCQVN4dXgPubDkDy4i89V1YOx5lEW9_n0XrmaUDMetaAuQoMxfnO2XliT7oC-KFuzgJy80O3HP97nJxMq)
22. [harvard.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHLAQoERpPVdXj5HKLEYVdDlv0DohvF9R6xHj3qkpxDwgAr1s_bQJxP5s_xfTjyBTconYOk21ivAk9B-aZRePKGr6fx7rKksu9t_JBVvOVEI2GSFgMZ-pfBSGX-32eZ5EyQU1i3wGo58CHFLdyUbR_3S25wVelGIJdwSGGYr98AMr23n2UJyWAr6GnGrn50vQweYSZGsJ1HOwNBhJB9A3ymIEqgE4oyCVzgPN9DDhUh1N7G5klSNJUTPVEwxYOcbztUtgB_H9mFp5r8zSdhazB9xcqab77gcNT1zspiQnUTtBwWniqCdzoo3GQjXEkVOfmT4x7N7eBivz4r3rm8m7R2W69g7_53BA==)
23. [broadinstitute.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGgQ5CoK-WAwB7SZ1jWroHtAzqS-RfueYmCJrp0EO290xvVfkZyP7z5DnnYY59mYi43mtJWerX2svTPyWOVL0dWvjmEdtFT9Ow_1TYVdxwjOIqVSc0ge5HQXUUaCFdbXMCJFSMCRaXpKan_6yQdvA==)
24. [mountsinai.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHVVFdCMUrvXyk7xjJLL_YME43__T7VHq-0ctQSG2-17dQolbuEBkM4sC3Tcbxl5CHwO7LpMOGpUX9HVZc19k66r1hMxH2MruJC5Mb3QjykL5dg6PeI9rfT7GJagRx7QfbbanKAm4LoFSCngGcX-xDVM8Z2RYduIk0J9NOVgEWeyEjiMXrL-nXJjhd4)
25. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEw7OGHSStHCk1sh4-e8oZk-QmaqTBHErlEUd3zsMFXzAU-2t_90GAoReLwoUrKTWuQA5y74kyaEiZvUNSqYFYmebDuJR5afk9Jt3nB99LqxfMBhZMUgOOP_hte73icSaCwCc6ED4vpx3n9GO_oOGhQnhU7H-d5G4OoAy9pB6OQCNzaGCLDN3ZkdfmM4uacXFZ0kEdZ6uSTI5zBea1oBO8rR9R-zmX4c9bQjUvSA_lSdLVVsX5sIsDBEBmyQ3Y=)
26. [wustl.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6Fsol8bRiPetKg-bTeWlWoLZ6YBAShgeF5POpVQ_-bKRf7or_SVk2Ekk3OQoh6PH5j6MbQ0_UmICbCRiIEJgydsN-Ug2rMitOR2N5ZU55-fCMXyuToIm9Ibbp7ApHEwPMk87dR_mOsq7YIqXaCNfZSprEu8hXLvSbSF0p_VdPimC6jihqwDK95R_hnv0hFud0PSMlVdWXVxaKMeLpGsixADQD)
27. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHPTGNpyJ2szGMqS1QXaaGvDFGNaAPrWGawRKFR0zsRPqDHPgQa5eM2pGtE_-rUnTqrtJqbOMfE5hzRSl9XCQYP86IRIpspBzHRe1TjaZ8UBGVQVkthqJ-hvh6bNpRtO3QZ7YMXRKf-Tg==)
28. [frontiersin.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHTCGK9TWookEetVO6VhMqlxJwyWBFa_u7agCbCZfje3IRUWc6K8KTdMjb2YunwHZ3pp_bIoEKS_Zg4qcGlRcaUv_anbzhB3yqsDQI28X5FHFosj2ECABnImxWzltocvhx7krRP9gF8xNmWtFTmPLMiP9yqrozFBNThifwvPYqVJqvx9JrE-XJAvOJmBd0TtdPx8CUTB10=)
29. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFAQx8Sxrr9eTqS18ldKVbcaIxzuEId6DlIFK2iLVlAbRmbrrVnjxcwnABzVlxCzaXW9117RGj9LCcKaMs8q2m5ghyVsKRSm4h9IMOAQEeQYvOwtJKOn2NNBcECxFE3YI3G29vASqrnMA==)
30. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHDJ-yvW8SO2Esap2eXC_UjXROVZFiMbObvvXAoJ6ufd4lW17wp4YnR30u6yuwG42AWkKO3soHgCrqWtIOKoXyjYbpmxzKUhVmlBY3dYLkv5Fzp6FCIxSPt4w-cbhokKw==)
31. [fiercebiotech.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG8Nfb7LtKfMOsadRb_4UzIBZR9uRvxmzpgEIwGpWBFSAb0ZLcBjvlLOonv5mRqKDkrsVN0tN7pwBhunQqsZmeyWhpj7o7xR9sui9PVVVRDP5-_Q6p_IC4lGZwcNhsKtCrsUOVhxxQb-vaz-BM1UiSncpdG5JgyMBLcwgh0iqngL5cIns-z4z1y26-XwNSzzYJXc3T0qz9aGHqlhqyf0MTLLWqiVeI7pUB3)
32. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFu_iTAGFYP9-hhUbRHdn09NxT7--PibW0E7IWETT_QPUuxXzKfXLMJRFQdzQIxwxRDo0HKsYsR1rz8nsU7nHBm7wf2flt-VTEzunPalhL_Rl9bpcCwQ5z3VeulpNp1ow2KyqO9OqwWVg==)
33. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGv591D5ziQ6x5cdexQGKq1O4nwq8E94UbWzkMxfNonDIVIngjwYbj1-zXnwXLPizM8d_9ly3XGp4fVBnenupHdly2t2zgJUr3JHFCrDa2gcvGHP_YO6AjFJ5WvTNU4H9YcO0uAwa4uTw==)
34. [alzheimers.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGHfkwoyyH3BE8Aqp9wWQtJbwfBbU26R_uQOFxRhDO9fvYGxioHqCoZIS11oXljQJvtT028ARnamA4l5TGtuCOqv_WkAG166qbWTwFAmD2fX3aUo_Y7RfhjK1W-RdsyJY8Psvjyg5paYdKufOerQAm2yhDRvI4JC4_FU2hi-YV77qfmkRkKGzqy8e0qFEjLmCLNsbksgNxnJDQ1naU=)
35. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHTHKvHPNx-wyiBHJFZGaDXy4kTrJwhmNqyu_9OEJrB0v8AWtQNVtNQSf4HP1RtufUXxFXmoVCdCMAe_Y3IrdlCHQHFbvUHWOWmfykg5Jz8V_YNbPJZENzUcoQMhiEI64o0Qlo9CU10Mw==)
36. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEnsJEhcEn3IBsc6VigZRznxQBsK_nSM2SOKCRNegDb08jjHYrhY2Ao0cU795h84uN1oboJuKuTiOlr628e0mj3Ye09SpQcSXGW2GShE9Lw3VaEwPupblmKHIpsCLW35XGkt4Bj1dYtmA==)
37. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHmLqRNcOOXZ7nltsJ1JV3MUJlIAZjE7SAUMEaa5dWwaUahvRtN5J_AwQeijgfNFLekNvesoN0_t45EULmuEVSHgI1PzOsJuwLLNpYsj8FyKS53wEb4FnXOZ1tHLLgvb3vl7Cqpszilug==)
38. [fightaging.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG0XLxJ3jlg-B47I5W5IHZ0vSVUciK68W3Q4Fv5QFRGwaTIFxOmu01Ba6LiWnUQS6aDcT5920NvWGUbaJljlgbcZfoSCC8hs9QjBtsIq6wo3guTAJpf4WTVa2eiLgTPXz4xaB363DxAXRCEnd4y9xm80o5v56EICQEy7et2YXWoa386SrbSsR4K7hFyortSF3dl8R70fHMnX9-e5RfHwqU8VJWfnm0p5rpKKkCxKOJAtNEBGW02-dRcOSJ5Uq-d-TQ0)
39. [neurosciencenews.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFa5j7OurvWmpvWhqd5hLBOy5izc_nrzMjALuTJjBSRmHq3W0InaYgmwatm_75FdyEW6kPk_U9I7aQIX5J5RV54IV_m0CFLPgKIjhq7O_22W-_E3gt4T1nr28ePOII5cq819bBwrLbhhpymIpkLrzBwqO34qKcqGg==)
40. [oup.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHckmZvPyFNryf-rxxwQ_A_6QNABnYgDnG0NmrgOcRkve2tq8lwQymvKTJ8SlUvJiMR5Dh7QC5qyeE4qZZ9FuG8S2c4jyZZkYfmCEwLQyUHNXlAd-OPvtWkrCMHkZI16EUDjJoOmwMnvKoTDWEYSA==)
41. [elsevierpure.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG46EqwiAt4erNo3VsxD6kWLa2F1KjYZx-Ea1_U-SoVZQzU8JQMOc0QREl5U_aJwjG2YjnmNsRrDGJDOYBnot5oXWTyCp5KvEpAiK7-lnJQ1lB9YzKT2ckCSY--Pg3kQdqXS3UAHEISOjyexl-IHeNt61h06ezuS2WUCHER1ILrMUS2hJ_jtUZkTrJVvB9wGQ8ZxHgacJk8AIM1H9ooGY4F9dVRBbSvhdiq0mEG)
42. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqTf8fPhkHfeqbOimMlZnr9idQU3MYHj8m6xoZxZV8ycbcA0UvAKHPhU3RYrp_vCIJuF3Dy2s0cQxNh54KwsMRWQjZeoHATJDa7khiS8NVYUjm-bdeqgujaLtCEZIkcYqR9hdxw-kh2A==)
43. [uef.fi](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFJxz4M13FRnNbD290E7esKCerH_vdPNX7Ln7jA17puai4wmY-DPUrzgDJ5p0sOwD0rietaWKNJffuVDGHMBqfwu2iEM2hvbvgmfic3lBrJnP2-dJfemOotuN2rEEwIPJyvW8dZwSU6fpeSXDNG_rXHbNitMUM7yGZIv_VDrN2vwY6A8A==)
44. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEpcPF-dYlYbCGm70s2JLD4_5oqeMCyPtN2RRG83w_fOzqkruom4HXI6XPAT6W7nAyNRJ_-OSDJtZePmPmRtWAYxIBdfCBE5AMII2C_s9XDwYVBPLKUCBSX2UTYqjtmhg==)
45. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEAuJlcdcvUzxAJPFt1ESZ2hKs6My3eQTsqWX3rFPXht54ujzR2xLK2KHue5QJDPIh_Mn4n2c9RRmEc-PEcn3xLEUJDX_ogzm_LsZubOEP35eB06cj0rh_9Iz50DGfw)
46. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHVbV7jCPZryp6BtOsX35syMzTTqz19pcOcOPDtcWSS6bxqRhx0TAmMbpa67r5bS_HDnzpP1ttSi2fcYfiq_j4Ty2G-jA4Ge8Oe34GnX6zDJSfzKef-TAPml4if9OGRUP0oiTp3qYn_qQvVQTkfYofDAd3HR6KkNUCl004dt8Xt-y-UJD0NjoAKtzw-CNhAAhwL250nFLw4Mncvf0v5pVzWUeVFJg-QkzGgYK4lH3k6ajMEGqe_zjE222gtCMjjF67xeE3EoQ==)
47. [ahajournals.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG1cgXqw41vK1QtEwn9VXMWEhU19SOGpmyJO7S1fqEvscpfRuaRUDhxXvC7vSMo-q9snz8lpmykl4B3ZDo1Gy8fxGQwKuQ8F7EGm9JCJTP8uQggMPwS4DW3x_qKbmMJfp382f1TauC8pP0GiKSwYRPldt7z)
48. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHxpHtVBYauh1WPZiJ6eozRIEnnAIyPbQk-TgZ6pyJrLiXVGRzHrzuDk9Slpom_BXDkFxhLAKBLDlZAZSCuLMmzl8M0-0T1pigJ9Ixad1E3V8zwBl99JxJoyLvl-MOGjB-SsqSUJVktTQ==)
49. [lymphoedemaeducation.com.au](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHs5o10fRjDH66q9qcK4DxkxtuFLgXfvd9ivvSeETB41cfEDabFkowNOwYdIZ49_fSZGdbtgmk0i2BExj3DJsY-otK-2XdYuoHMTHg1nlr-gyvtm92zyR0HZx9jrsqmx0eNVEwyDME_wM79GyH9yW1MR8yrCmc94F3DyyCCbImFeH1TPvY4Zox3hTanAZbVioR5t-xV8wKSvavcz5ArUuMTD3lXeeZR-PJ6ljtThZHRo1-I_j80IFJQOXwiVnSy)
50. [alzdiscovery.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGwm5ixcyxngJFycww9vwy4uzmwMDjKDc5UKAHEiTwfvzP6JoudKryJahSjxUpPPklPFh4WG1qThhiUEZS9dimWZUHbhUUkejjA3EuKSBIwAflWudQwZtnPP7W672MzFIjeE7wyprumL3FgWN8sGLPMifXnYYz2APPq0s5rd8lZbYCJxxCJufNz26zLwH7Bw5Rmml0FjtgDF3OJYR-kbnkTCWR31A==)
51. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFhGlK7Wi0cBexMyhJrasO4m800316u_caPHF_nt6antoA6NsHe_YX64WRbr_vFg1eHpR_kFMYTXys6B0dTeU7lzq7NCOPaXyges8mdn7_7cYf9378hGrvePnly7rVThw==)
52. [drstavy.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEhqeCwswzzYrJ-FUzpvu_ARbD9PNOuDY1lBa-TRndCvEIu8E00IgDF7JP86w7U_TkSH8itMwPNflDu8RkLbRLg8CGsUK_AYJTVFGV1Xf03dwqeO3BTbs1aTMpOzbkCZ1pOnfmqaJCX4Uz0kDdbZPqKtR37OQBW4kkw01ShryiOIg==)
53. [longevilab.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHjuPEP74p05U-DYjT5fU_hfrl20486z-yL6fuW5tJCpcB2YffqZ-ltYYGfyBY7WGJNb__mxjKn-7t-Cf3dWdEIIpog_Yl9k6c7R_nuo5uPZyQFtRbqw_0cYxhAUK5RyRk7PdyuuwhptQ_qifohyh2W4C9xMknfSLZOOW4=)
54. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFRqMbCD69uDd9vKsK0T85S0UegQcyjrMGGiTT09ihofeKtm9eQGicPbnl6BAGKmuX_rKpg78HfEbt8-6NlNmu28hNLhUH2-Jrjsnl0FMx89AjLOqudS8l-EeHXbw7Yo_CDjio0TI8DuQ==)
55. [fightaging.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGYGeyKVwAaQUDSaRH7UNXvw4AODFw_XXlXDqYppSRh51jRnlzbzn0s7cuTbCYvumOnu0iymww_A4S4RTp6D985sGKsdKbGvQDQybjd2b4I08vWZ6EcJX_z1qRPIMssbq0eYWkPZMZfaYwYx2vdrwmz5QmFObwxTgzZg9WGf4HnI4Fa6g4-K3METLKZr7T4Glfk_pE1aiBCQ31OsA==)
56. [alzforum.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFDbckEV0hkFsLOQh7RzvOPQo9_IAnw7VwuzmuoD-eaOB-HJ2okTSIY8e-daPqZZPrKhm4xRTUUCvbzmTkEFi3RGe251RZSgZEB-I12VGUu7gFmN7F_6mONxMmBM_FfH1KN87onZP5QEvEG2uRK2p__FXOhc-ZdDuvFandZjtm66Z4fUGW0AbU2kedhSrPVAh6aCdSbcdd8AFbcLbG1M4Yy)
57. [getgutted.co](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHALU9EDbEBY623XhJpsjUDMfVSADbltwadt7BXPRawg3RXNLbQQhdoSVR9gpXsppwoyurpkXqttnPWP4ZI0wsm8YEEzPtHART5c9ZkBeVAvHLPpU9ggrM_LXNHIkvqC44vC6qd2snaVb1wgcJYFeGd0_GzqVowflx39IO9LRjwkf5X51Sd9hZ6eyg2)
58. [ubiehealth.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFkAd7JPM-R3_rGIIRftBgQcqV1UWViEJTHY2CDJ6BkMTKWlXh9qnIOD8lF-aBjCd8mpF--Z7_RmS1cnQC8YEZgApLyQNKHHg4C8yUP3QNRZkNZh9ciPdosMy2igWKE90K_ZAWiK9qoR55iNFnYXFhLONhMGSIWXCgtY421kHVFNB3b8y1OIWxUe_XGlV2stxA=)
59. [bcpp.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF_vgb32M-NAj2eyVLVM3GLFz4bYdIiYzDyMNZ97r9ZnhCIqFgiAZL6ZYFZEcSEjorzcGgEDqLu0CMvVfwAyD1lwvxY09MQmvQRZrlPD585dN1gZuFlu6VoGTcdGhQd8zcnVGpu2y1UC6rJbt7Ueqw4LBu_uvaK5g==)
60. [withwonderandwhimsy.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHkFDag1emRoBgEpzGFH2B-mU4yWFqTPX2BhpARPPaCXOxnGdlWWpxmFVPxlFkEImnP-jhyaLxZGrhXYXa6lT2wdGCTbpGlOothEqkDdbygsqIJt3tkwrwoqg3RIlmmaxoyPj6B47CyNk8wRwnu3vuHOlmR4NsF-sLw7K9dvjXDdlp_OG7UFZDCtAcnOkVNE7Y0g7v9_kiPp6MXSoRj8Y-oCVh1vgQQm1FfTMr_)
61. [medanta.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFzUS47_Q8nBBLM71nOfGA01m21i48yyP7zjH-rjKWIcKjNqbJQBLuY4LplOT75Rl8Wm01mIObJGNERze0wHFCjWAV2qV2UNjwbH82zxPbbsGxub99GP7ROpiTZSnd3Xm9GmECtPFMqmMSJyqOJQBckKHSJPPeeifLYMZU4irFWUn-55g9P5ib35QL0uJsxr0rfRL0Qivg6LdTQvnjJF4JUZsPvg2WJDBViz0sr2yZMRaYaH9htn3et9rs2PdMGfjg1KSXknBgqMV1bRPDVZ-Y7zL-bHfXMHr7emDn01ISO7f4nqRvmB5HdVXT3Y-ISGh1l5rK1mhvNmS19cuRUVIJ_GIQNvGlNcWEONdFX60o52yHyq0LT)
62. [newswire.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFbp2az86niJW6eLC9_b3VdHLENHHXhK2itN4BPlzYEkCfy9VnOYN8rp3RAy9kcDpI5rVBUauFZT78tP_ncrT84gYLMa6FxCN8Lnvrh-jKiai_g23phK82BE32P0RzclqfG8lMD0QFjBrzv0U-4WotDfLeklqj1DoOQIMcvwi6jUA3jdGoCa9KB6GCh-9dN4WvUwr7Y_RjBMNVywyolMuZAV_o=)
63. [lemon8-app.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGJm9N_nlO42LxEtJnLeAmF6wopiMLOluDQFccyjn9L9CLVCCRKm3GowsYARoxAOsb4fg9RsXS-G6AAL5bVgCrseNSkFhtrJjHdHXoxtySaV7E9lkPLBbgURsBwGIuo0jZUTEF4MI29t9Hf0j-gSsLVCVOcp_mky78MOz_49Dc=)
64. [boots.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFssU_p94WSiDjcz8-ru1XncIQbhTynDhyndp07t4bOsqgwhe2nIV_RM4EzMoVXAUiL9NGQyYR_3YH23SLGi7ZPra5CUvRXz_Z-kCq53pBsbYoRABouKawof3gKMFnWx4oVtf9KZ5WdVYRn3bkDMKBsXxX4_del-Q==)
65. [youlumistore.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHgKIqAYfhgHa6iuCcEs2uUSyLv2Gc02h484ZS7bzF-clJP_fC_klfNLtqXQ8dkDEZgKDDTR8DEYZeFiqGWAc8o2USg2hEnEvfAm3AWzpZrmJbPiTywtvofEVgfOq6kQeWs6EKXnnDchThmljpjXfcfDFDLyBAFT7lIua21PlFFSwpfjF4fYi8AK8wpZS4awpn8OFE2b7XgdF7BUA==)